18 results on '"Hidalgo‐Simon, Ana"'
Search Results
2. BJCP-EMA commentaries on the guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells.
3. Regulatory approaches to stimulate innovative renal replacement therapies
4. Comparison Between Paediatric and Adult Suspected Adverse Drug Reactions Reported to the European Medicines Agency: Implications for Pharmacovigilance
5. Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions
6. Authorization of Vaccines in the European Union
7. Advanced therapies are ready to take centre stage: Academia's involvement with regulation needs to raise its game
8. Environmental risk assessment of advanced therapies containing genetically modified organisms in the EU
9. Towards a better use of scientific advice for developers of advanced therapies
10. Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth
11. Pharmacovigilance in Europe: direction of travel in a changing environment
12. Evaluation of the effectiveness of risk minimization measures
13. From Laboratory to Patient: The Evolving Path to Become a Medicine
14. Towards a better use of scientific advice for developers of advanced therapies.
15. Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth.
16. Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice
17. Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review
18. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.